Also known as: ECDC
The European Medicines Agency is enforcing clinical trial transparency and has launched a new vaccine information initiative, while a coalition of health professionals warns of suboptimal vaccination coverage across Europe. An analysis also shows that only a portion of EMA-approved medicines are available to NHS patients in England after additional assessments.
U.S. hospitals face a 461% increase in NDM-gene CRE infections, while European data show high antibiotic resistance in foodborne bacteria like Salmonella and Campylobacter, with ciprofloxacin no longer effective for Campylobacter.
New market forecasts project growth across several life sciences sectors through 2035, including tech-enabled pharmaceutical facilities, biologics safety testing, central labs, microscopy devices, and biological safety cabinets. Key drivers include automation, AI integration, regulatory mandates, and expanding biologics production.
A joint report from the European Food Safety Authority and the European Centre for Disease Prevention and Control finds antimicrobial resistance in Salmonella and Campylobacter continues to pose a public health concern across Europe, though several countries have reported progress in reducing resistance levels.
